CEO Executive AssistantStarting with a virtual EA service for pharmaceutical and biotech is one of the highest-leverage operational moves available to a pharmaceutical or biotech CEO. The operational case is clear; the question is simply how to start well rather than starting poorly and spending three months in a frustrating ramp-up that produces little value.
This guide takes you from zero to an EA who is actively supporting your pharmaceutical operations within two to three weeks.
The Starting Point: Getting Your Requirements Clear
Before you contact any service, invest one hour in writing down exactly what you need. This is not bureaucratic overhead; it is the difference between a service matching you effectively and matching you generically.
Your requirements document should answer these questions.
What are the three to five administrative tasks that consume the most of your time each week? For most pharmaceutical CEOs, this includes calendar management, travel booking, email triage, investor communications coordination, and regulatory calendar management. Identify yours specifically.
How many hours per week do you need EA support? Be realistic. If you currently spend 10 hours per week on administrative tasks, you need at least 15 hours of EA support per week to fully offload those tasks (because some tasks take more time when explained than when done yourself, especially early in the relationship).
What pharmaceutical context does your EA need? Do they need to understand regulatory affairs calendars? Investor relations dynamics? Clinical trial milestone tracking? The more specific you are, the more targeted the service’s matching will be.
What communication standards do you require? Will your EA be writing investor-facing correspondence? Board communications? External partner emails? Define the quality bar explicitly.
What confidentiality protocols apply? What systems access will your EA need? What NDA terms are required before they can begin work?
Selecting the Right Service to Start With
With your requirements clear, contact two to three managed EA services that serve pharmaceutical or life sciences clients.
In your initial outreach, share your requirements document and ask for a consultation. The quality of the service’s response to your pharmaceutical-specific requirements tells you a great deal about whether they are the right fit.
Services that respond with generic executive support capabilities without specifically addressing your pharmaceutical requirements are telling you they do not have a differentiated approach for your industry. Services that respond with specific pharmaceutical client examples, questions about your regulatory context, and matching criteria relevant to life sciences are demonstrating the right competency.
After consultations, select based on: pharmaceutical client experience, matching quality, pricing, and the quality of their NDA and confidentiality framework.
For a comparison of which services serve pharmaceutical executives most effectively, see best virtual EA for pharma. For a detailed look at what part-time service arrangements look like specifically, part-time EA for pharma covers that option.
Executing the Agreement
Before your EA starts, ensure these agreements and protocols are in place.
Service Agreement: Review the service agreement carefully. Confirm the pricing, the hours included, the overage rate, the replacement guarantee terms, and the exit terms. Pharmaceutical CEOs often overlook the exit terms until they need them; know them in advance.
NDA: Execute the NDA covering all pharmaceutical-specific information categories your EA will encounter. If the service’s standard NDA is not sufficiently specific for pharmaceutical operations, work with your legal team to add appropriate riders.
Access Provisioning: Provision access to the systems your EA will use: calendar, email (with appropriate permissions), document management, and any project management tools. Set permissions at the minimum necessary level initially and expand as the relationship matures.
Your First Week: Setting the Tone
The first week of any virtual EA relationship sets patterns that persist for months. Invest in starting well.
Day 1 Onboarding Brief: Send your EA a structured briefing document covering your regulatory calendar, key stakeholders (investors, board members, regulatory contacts), communication standards with examples, scheduling preferences, and the information access protocols they need to follow.
Day 1 to 3 Calibration Tasks: Assign your EA three to five representative tasks in the first three days, each from a different category (scheduling, travel, email, communications). Evaluate the output carefully and provide specific, constructive feedback. This calibration sets expectations clearly and gives your EA the feedback they need to improve quickly.
Day 5 First Check-In: Schedule a 20-minute check-in at the end of the first week. Ask: what went well, what was unclear, and what questions does your EA have? This conversation surfaces any misalignments early.
What to Expect in the First 30 Days
Be realistic about what month one delivers. You will experience:
- Some errors, particularly in the first two weeks
- Moments where the EA needs more context than you expected to provide
- Gradual improvement as your EA builds understanding of your operation
- Some time recovery, even in month one, as routine tasks are offloaded
By day 30, you should be experiencing meaningful administrative relief and should be able to project what the relationship will deliver at full effectiveness in months two through three.
If you are not experiencing any meaningful relief by day 30, do not wait another month to address it. Contact your account manager, provide specific feedback, and request a calibration conversation.
Research from McKinsey shows that executives who establish clear performance baselines early in administrative support relationships achieve full value significantly faster than those who wait and hope improvement happens organically. Pharmaceutical CEOs who define success criteria at the outset and measure against them consistently get better results.
The Two-Month Evaluation Point
At the two-month mark, conduct a deliberate evaluation of the relationship.
Is your EA operating independently on the tasks you defined in month one? Are you recovering the time you expected? Has the relationship developed enough rhythm that your EA anticipates your needs rather than just responding to requests?
If yes, expand scope and increase delegation. If partially, identify the specific gaps and address them with targeted feedback and onboarding additions. If no meaningful progress, escalate with the service or consider whether the match is right.
Most well-started pharmaceutical CEO EA relationships reach strong operational performance by month two to three. Poor matches reveal themselves in the same timeframe. Do not wait six months to address a poor match.
Conclusion
Starting with a virtual EA service for pharmaceutical and biotech is straightforward when you define requirements clearly, select a service with genuine pharmaceutical client experience, execute proper agreements, and invest in a structured first week. The path from first contact to active EA support takes two to three weeks. The path from active support to genuine operational leverage takes two to three months. Start today, start well, and the leverage will follow.
Related Reading
For further context, explore Start With a Virtual EA Service for Automotive Today and Start With a Virtual EA Service for Construction & Architecture Today.